FDA Approves New Tablet Form of Evrysdi for Treatment of Spinal Muscular Atrophy
About Evrysdi Evrysdi is an SMN2-splicing modifier designed to increase functional SMN protein production. With the introduction of a new tablet formulation, Evrysdi now offers an alternative ...
Humana Q4 Earnings Review: A Tough Quarter -- And A Rating Downgrade
Humana's 2024 earnings reveal revenue growth but major structural issues impacting profitability. Learn about risks, new ...
Marker Pens - Global Strategic Business Report 2025 - Features Analysis of 42 Major Companies
Focus on Eco-Friendly and Refillable Marker Pens Drives Innovation in Sustainable Writing Instruments Marker Pens Market ...
BW Businessworld12h
Massive Rs 800 Cr Contract Boosts Pulsar International: Experts Predict Share Price Surge
Pulsar International, a prominent name in India's trading, financial services, and consultancy sectors, has recently made ...
Asian News International on MSN14h
Pulsar International Limited secures a massive order worth Rs800 crores, likely to stir the Indian financial market
Pulsar International Limited, a company that has established a strong identity in the Indian trading, financial services, and consultancy sectors, has made headlines with a significant development.